|
|
VSA-3 Adjuvant |
|
Vaxjo ID |
36 |
|
Vaccine Adjuvant Name |
VSA-3 Adjuvant |
|
Adjuvant VO ID |
VO_0001266
|
|
Description |
The adjuvant VSA3 contains an immunomodulatory compound to enhance immune responses (Van et al., 2005). |
|
Stage of Development |
Research |
|
Components |
Contains emulsion plus DDA (Van et al., 2005). |
| Related Vaccine(s) |
|
| References |
Van et al., 2005: Van Donkersgoed J, Hancock D, Rogan D, Potter AA. Escherichia coli O157:H7 vaccine field trial in 9 feedlots in Alberta and Saskatchewan. The Canadian veterinary journal. La revue veterinaire canadienne. 2005; 46(8); 724-728. [PubMed: 16187717].
|
|
